TAG-72 Expression in Primary, Metastatic and Hormonally Treated Prostate Cancer as Defined by Monoclonal Antibody CC49

The Journal of Urology

Volumn 153, Issue 5, 1995, Pages 1575-1579

  Brenner, Phillip C ^a   Rettig, Wolfgang J ^a   Sanz Moncasi, Pilar M ^a   Reuter, Victor ^a   Aprikian, Armen ^a   Old, Lloyd J ^a   Fair, William R ^a   Garin Chesa, Pilar ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; MONOCLONAL ANTIBODY; PROSTATE SPECIFIC ANTIGEN;

ANTIGEN SPECIFICITY; ARTICLE; BREAST CANCER; CLINICAL FEATURE; COLON CANCER; DIAGNOSIS; DIAGNOSTIC IMAGING; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; SCINTISCANNING;

ADENOCARCINOMA; ANTIBODIES, MONOCLONAL; ANTIGENS, NEOPLASM; BONE NEOPLASMS; FLUTAMIDE; GLYCOPROTEINS; GONADORELIN; HUMAN; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0028933909     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(01)67465-2     Document Type: Article

References (19)

1. Radioimmunoscintography of prostate cancer.
2. Monoclonal antibodies and radioimmunoconjugates in the diagnosis and treatment of prostate cancer.
3. Distribution of oncofetal antigen tumor-associated glycoprotein-72 defined by monoclonal antibody B72.3.
4. Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.
5. Comparative dual label study of first and second generation antitumor-associated glycoprotein-72 monoclonal antibodies in colorectal cancer patients.
6. Prostatic adenocarcinoma: evaluation of immunoreactivity to monoclonal antibody B72.3.
7. Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.
8. Phase II trial of sup 131 I-labelled high affinity anti-TAG 72 antibody for metastatic prostate cancer. Antibody, Immunoconj
9. Radioimmunoguided radical prostatectomy and lymphadenectomy.
10. Immunohistochemical analysis of human neuronectin expression in normal, reactive, and neoplastic tissues.
11. A monoclonal antibody (B72.3) defines patterns of distribution of a novel tumor-associated antigen in human mammary carcinoma cell populations.
12. Differential reactivity of monoclonal antibodies with human colon adenocarcinomas and adenomas.
13. A tumor-associated antigen in carcinoma of the pancreas defined by monoclonal antibody B72.3.
14. Complementation of anti-CEA and anti-TAG-72 monoclonal antibodies in reactivity to human gastric adenocarcinomas.
15. Phenotypic heterogeneity of a tumor-associated antigen in adenocarcinomas of the colon and their metastases as demonstrated by monoclonal antibody B72.3.
16. Regional heterogeneity and complementation in the expression of the tumor-associated glycoprotein 72 epitopes in colorectal cancer.
17. Heterogeneity of antigen expression in advanced epithelial ovarian cancer.
18. Tumor-associated antigen TAG-72: correlation of expression in primary and metastatic breast carcinoma lesions. Breast Cancer Res.